Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,147 | 667 | 697 | 161 | 1,206 |
| Receivables | 813 | 691 | 7,292 | 777 | 8,981 |
| Other current assets | 9,643 | 25,196 | 2,344 | 23,517 | 2,928 |
| TOTAL | $12,603 | $26,554 | $10,333 | $24,455 | $13,115 |
| Non-Current Assets | |||||
| PPE Net | 671 | 634 | 3,821 | 558 | 4,499 |
| Investments And Advances | 92 | 92 | 92 | 92 | 242 |
| Intangibles | 6,111 | 9,089 | 21,174 | 9,312 | 21,378 |
| Other Non-Current Assets | 1,359 | 746 | 3,072 | 989 | 651 |
| TOTAL | $8,233 | $10,561 | $28,159 | $10,951 | $26,770 |
| Total Assets | $20,836 | $37,115 | $38,492 | $35,406 | $39,885 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,273 | 3,101 | 11,192 | 2,481 | 8,764 |
| Accounts payable and accrued liabilities | 3,330 | 2,777 | 11,561 | 4,598 | 13,040 |
| Other current liabilities | 5,198 | 24,165 | 1,555 | 621 | 1,500 |
| TOTAL | $12,675 | $31,908 | $28,319 | $28,148 | $28,339 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,607 | 1,622 | 2,604 | 1,214 | 2,409 |
| Other Non-Current Liabilities | 549 | 127 | 1,797 | 248 | 1,122 |
| TOTAL | $697 | $267 | $2,494 | $456 | $2,298 |
| Total Liabilities | $13,372 | $32,175 | $30,813 | $28,604 | $30,637 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 420 | 402 | 385 | 375 | 185 |
| Common Shares | N/A | 6 | 6 | N/A | 3 |
| Retained earnings | -164,131 | -166,106 | -162,333 | -157,716 | -153,951 |
| Other shareholders' equity | -101 | 19 | -16 | 60 | 104 |
| TOTAL | $7,464 | $4,940 | $7,679 | $6,802 | $9,248 |
| Total Liabilities And Equity | $20,836 | $37,115 | $38,492 | $35,406 | $39,885 |